• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SARS-CoV 和 SARS-CoV-2 特异性共表达网络介导的人类肠道肠细胞中生物学过程的差异。

The differences in SARS-CoV and SARS-CoV-2 specific co-expression network mediated biological process in human gut enterocytes.

机构信息

Department of Life Science and Biotechnology, Jadavpur University, Kolkata 700032, India.

Department of Life Science and Biotechnology, Jadavpur University, Kolkata 700032, India.

出版信息

Infect Genet Evol. 2021 Aug;92:104892. doi: 10.1016/j.meegid.2021.104892. Epub 2021 May 3.

DOI:10.1016/j.meegid.2021.104892
PMID:33957338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8091811/
Abstract

Novel coronavirus SARS-CoV-2 was recently outbreak worldwide causes severe acute respiratory syndrome along with gastrointestinal symptoms for some infected patients. Information on detail pathogenesis, host immune responses and responsible biological pathways are limited. Therefore, infection specific host gut responses and dietary supplements to neutralize immune inflammation demand extensive research. This study aimed to find differences in global co-expression protein-protein interaction sub-network and enriched biological processes in SARS-CoV and SARS-CoV-2 infected gut enterocytes cell line. Attempts have also been made to predict some dietary supplements to boost human health. The SARS-CoV and SARS-CoV-2 infected differential express proteins were integrated with the human protein interaction network and co-expression subnetworks were constructed. Common hubs of these sub-networks reshape central cellular pathways of metabolic processes, lipid localization, hypoxia response to decrease oxygen level and transport of bio-molecules. The major biological process enriched in the unique hub of SARS-CoV-2 significantly differ from SARS-CoV, related to interferon signaling, regulation of viral process and influenza-A enzymatic pathway. Predicted dietary supplements can improve SARS-CoV-2 infected person''s health by boosting the host immunity/reducing inflammation. To the best of our knowledge this is the first report on co-expression network mediated biological process in human gut enterocytes to predict dietary supplements/compounds.

摘要

新型冠状病毒 SARS-CoV-2 最近在全球范围内爆发,导致一些感染患者出现严重的急性呼吸系统综合征和胃肠道症状。关于其详细发病机制、宿主免疫反应和负责的生物学途径的信息有限。因此,需要对感染特异性宿主肠道反应和中和免疫炎症的饮食补充剂进行广泛研究。本研究旨在寻找 SARS-CoV 和 SARS-CoV-2 感染肠上皮细胞系中全球共表达蛋白-蛋白相互作用子网络和富集生物过程的差异。还尝试预测一些饮食补充剂以促进人类健康。将 SARS-CoV 和 SARS-CoV-2 感染的差异表达蛋白与人类蛋白质相互作用网络整合,并构建共表达子网络。这些子网络的共同枢纽重塑了代谢过程、脂质定位、降低氧水平的缺氧反应和生物分子运输的核心细胞途径。SARS-CoV-2 特有枢纽中富集的主要生物学过程与干扰素信号转导、病毒过程调节和流感-A 酶途径显著不同。预测的饮食补充剂可以通过增强宿主免疫力/减少炎症来改善 SARS-CoV-2 感染患者的健康。据我们所知,这是首次在人类肠上皮细胞中报告基于共表达网络的生物学过程,以预测饮食补充剂/化合物。

相似文献

1
The differences in SARS-CoV and SARS-CoV-2 specific co-expression network mediated biological process in human gut enterocytes.SARS-CoV 和 SARS-CoV-2 特异性共表达网络介导的人类肠道肠细胞中生物学过程的差异。
Infect Genet Evol. 2021 Aug;92:104892. doi: 10.1016/j.meegid.2021.104892. Epub 2021 May 3.
2
Competitive Endogenous RNA Network Activates Host Immune Response in SARS-CoV-2-, panH1N1 (A/California/07/2009)-, and H7N9 (A/Shanghai/1/2013)-Infected Cells.竞争性内源性 RNA 网络激活 SARS-CoV-2、panH1N1(A/California/07/2009)和 H7N9(A/Shanghai/1/2013)感染细胞中的宿主免疫反应。
Cells. 2022 Jan 30;11(3):487. doi: 10.3390/cells11030487.
3
SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements.SARS-CoV-2 感染介导人类内源性逆转录病毒和长散布核元件的差异表达。
JCI Insight. 2021 Dec 22;6(24):e147170. doi: 10.1172/jci.insight.147170.
4
SARS-CoV infection crosstalk with human host cell noncoding-RNA machinery: An in-silico approach.SARS-CoV 感染与人类宿主细胞非编码 RNA 机制的串扰:一种计算机模拟方法。
Biomed Pharmacother. 2020 Oct;130:110548. doi: 10.1016/j.biopha.2020.110548. Epub 2020 Jul 28.
5
Dynamic changes in gene-to-gene regulatory networks in response to SARS-CoV-2 infection.SARS-CoV-2 感染后基因间调控网络的动态变化。
Sci Rep. 2021 May 27;11(1):11241. doi: 10.1038/s41598-021-90556-1.
6
Pathogenesis-directed therapy of 2019 novel coronavirus disease.针对 2019 新型冠状病毒病的发病机制导向治疗。
J Med Virol. 2021 Mar;93(3):1320-1342. doi: 10.1002/jmv.26610. Epub 2020 Nov 10.
7
Mechanistic Insights to the Binding of Antibody CR3022 Against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: A Computational Study.抗 SARS-CoV 和 HCoV-19/SARS-CoV-2 RBD 的抗体 CR3022 的结合机制研究:一项计算研究。
Comb Chem High Throughput Screen. 2021;24(7):1069-1082. doi: 10.2174/1386207323666201026160500.
8
Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression.赖氨酸 164 对 SARS-CoV-2 Nsp1 抑制宿主基因表达至关重要。
J Gen Virol. 2021 Jan;102(1). doi: 10.1099/jgv.0.001513. Epub 2020 Nov 5.
9
Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.宿主-病毒嵌合事件在感染 SARS-CoV-2 的细胞中罕见且为人工假象。
J Virol. 2021 Jul 12;95(15):e0029421. doi: 10.1128/JVI.00294-21.
10
Molecular Insights into SARS-CoV2-Induced Alterations of the Gut/Brain Axis.SARS-CoV-2 诱导的肠脑轴改变的分子洞察。
Int J Mol Sci. 2021 Sep 28;22(19):10440. doi: 10.3390/ijms221910440.

引用本文的文献

1
Characterization of the gut microbiota in patients with SARS-CoV-2 infection during controlled ovarian stimulation.SARS-CoV-2 感染患者在控制性卵巢刺激期间的肠道微生物组特征。
J Ovarian Res. 2024 Nov 20;17(1):231. doi: 10.1186/s13048-024-01553-7.
2
Reduced circulating FABP2 in patients with moderate to severe COVID-19 may indicate enterocyte functional change rather than cell death.在患有中度至重度 COVID-19 的患者中,循环 FABP2 的减少可能表明肠细胞功能发生变化,而不是细胞死亡。
Sci Rep. 2022 Nov 5;12(1):18792. doi: 10.1038/s41598-022-23282-x.
3
SARS-CoV-2 infection causes intestinal cell damage: Role of interferon's imbalance.
SARS-CoV-2 感染导致肠道细胞损伤:干扰素失衡的作用。
Cytokine. 2022 Apr;152:155826. doi: 10.1016/j.cyto.2022.155826. Epub 2022 Feb 10.
4
Differential Co-Expression Network Analysis Reveals Key Hub-High Traffic Genes as Potential Therapeutic Targets for COVID-19 Pandemic.差异共表达网络分析揭示关键枢纽-高流量基因可能成为 COVID-19 大流行的治疗靶点。
Front Immunol. 2021 Dec 15;12:789317. doi: 10.3389/fimmu.2021.789317. eCollection 2021.